A diabetes startup that uses artificial intelligence, Bigfoot Biomedical, has just announced that it scored a total of $55 million in Series B equity financing with new investments from Abbott and other existing funders.

from MobiHealthNews https://ift.tt/2GgMJgt

Related Posts:

0 comments:

Post a Comment

Popular Posts